Pilot Implementation Trial of Implementation Toolkits for Diabetes Coaching

August 26, 2026 updated by: Julia Price, Nemours Children's Clinic

Single Site Implementation Pilot Trial of Base, Enhanced, and Sustainment Implementation Toolkits for Diabetes Coaching for Families With an Adolescent With Type 1 Diabetes

The goal of this study is to learn if toolkits of implementation strategies (e.g., provider and staff education, clear plan for how to refer and bill) help pediatric type 1 diabetes medical and psychology providers deliver a behavioral intervention (Diabetes Coaching) to more families. The main questions this study aims to answer are:

  • Is it possible to put these toolkits of implementation strategies into place in one pediatric hospital?
  • Do providers and staff find these toolkits of implementation strategies acceptable?

Participants will be type 1 diabetes professionals (endocrinologists, nurse practitioners, psychologists, scheduling and billing staff) at Nemours Children's Hospital Delaware. Participants will:

  • Attend educational and/or planning meetings
  • Receive email updates on referral data
  • Complete surveys
  • Complete an interview

Study Overview

Detailed Description

Type 1 diabetes (T1D), one of the most prevalent chronic pediatric diseases in the United States, requires a complex treatment regimen. Youth with T1D, particularly adolescents, more frequently have higher glycemic levels. Less than 30% of youth achieve the recommended level of glycemic control. Compared to adults, youth are more at-risk for related complications (diabetic ketoacidosis) that can lead to heart disease, diabetic coma, and death. These complications often result from challenges completing T1D care tasks. Evidence-based behavioral interventions can increase T1D care task completion and lower glycemic levels (i.e., A1c). Integrating these interventions into standard T1D care may lead to better overall health for this population. Implementation science offers theory and rigorous methods to accomplish this goal, but few studies have employed them.

Behavioral Family Systems Therapy-Diabetes (BFST-D) is efficacious for increasing T1D care task completion and lowering A1c, particularly among adolescents who have higher glycemic levels (A1c≥9.0%). A brief 4-session, adapted version of BFST-D (Diabetes Coaching) delivered as part of standard care was associated with lowered glycemic levels. Despite these efficacy and initial effectiveness data, few receive this evidence-based care. Although Diabetes Coaching has been offered at the PI's institution, less than 10% of patients received it. Evaluation of strategies to improve reach of Diabetes Coaching in standard care is needed.

In a large national qualitative study of key informants (adolescents with T1D-caregiver dyads, medical and psychosocial healthcare providers, healthcare leaders) drawn from 5 children's hospitals, the PI identified determinants of implementing Diabetes Coaching (K23 Aim 1). Factors influencing implementation ranged across all domains of the Consolidated Framework for Implementation Research (CFIR), including those related to family needs and opportunity to engage in this care (evening, telehealth delivery, expert providers who are empathic, patient, encouraging, referrals from trusted provider when A1c rising, evidence of improved A1c), provider knowledge and self-efficacy in referring to and delivering Diabetes Coaching, and clinic resources (lack of streamlined referral processes; leadership buy-in), as well as external factors (insurance coverage).

Using these rich data and an evidence-based quality improvement (EBQI) approach with iterative feedback from Family and Healthcare Professional Diabetes Care Advisory Boards (F-DCAB; P-DCAB) drawn from Nemours Children's Hospital Delaware (NCHD), the PI developed a toolkit of implementation strategies (K23 Aim 2). Implementation strategies are methods for integrating evidence-based practices into standard care.20 Critical strategies needed to integrate Diabetes Coaching into standard T1D care at NCHD emerged and comprise a Base Implementation Toolkit (BIT). Pre-implementation BIT strategies include provider and staff education meetings (e.g., referring and delivering Diabetes Coaching), identification of and training of Champions for implementation, materials to increase demand for Diabetes Coaching among families (e.g., family-facing educational materials), and development of a workflow blueprint and of tools to monitor implementation. Active implementation BIT implementation strategies include feedback loop to clinical provider team regarding summary level data on uptake of referrals to and family engagement in Diabetes Coaching, as well as consultation to support problem-solving workflow and other implementation challenges with Champions. Two strategies (audit and feedback, adapting delivery format and timing of Diabetes Coaching) may be added to BIT (BIT-Enhanced) to improve adoption among medical providers with lower referral rates and/or to increase reach if few families attend Diabetes Coaching. BIT-Enhanced requires additional time and resources (e.g., Champion and providers review individual data, collaborate on ways to increase referrals). Thus, examining if this additional strategy meaningfully improves outcomes offers critical data for maintaining only the strategies that are necessary and sufficient. Key to maintaining implementation of any evidence-based practice, including Diabetes Coaching, is considering sustainability early on. The primary sustainability strategy involves training the Champions early and planful progression of their role in the implementation efforts, from first attending the PI-led (implementation and content expert) brief consultation meetings and data tracking to then independently leading these meetings (BIT-Sustainment)

Guided by the Exploration, Preparation, Implementation, Sustainment (EPIS) and the Reach, Efficacy, Adoption, Implementation, Maintenance (RE-AIM) frameworks, the goals of the current single site pilot implementation feasibility trial (K23 Aim 3) are to pilot study procedures and the implementation toolkits and track effectiveness of implementation toolkits in preparation for a fully powered trial. The overarching aim of this study is to gather preliminary data to support an R01 application to conduct a large, multi-site randomized hybrid implementation-effectiveness trial testing uptake of Diabetes Coaching and tracking patient health outcomes.

Aim 1 (Feasibility & Acceptability): Conduct a pilot implementation feasibility study at the PIs institution (NCHD) to examine acceptability and feasibility of BIT for Diabetes Coaching and BIT-Enhanced for providers with lower adoption rates (<80%) and with low reach (<5 families per group), and BIT-Sustainment. In addition, study procedures will be piloted in preparation for a fully powered trial.

Aim 2 (Implementation Outcomes): Examine four exploratory implementation outcomes, (1) medical provider adoption of referring to Diabetes Coaching (i.e., number of providers vs. number of providers referring >80% eligible families), (2) psychologist fidelity in delivering Diabetes Coaching, and (3) reach of Diabetes Coaching to the target patient population (i.e., number families eligible vs. referred, number of sessions attended, completion rate). (4) Sustainability of adoption, reach, and fidelity will be examined following the removal of most research resources.

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Delaware
      • Wilmington, Delaware, United States, 19803
        • Recruiting
        • Nemours Children's Hospital - Delaware
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Involved in the direct clinical medical care of adolescents with T1D at Nemours Children's Hospital - Delaware OR
  2. Involved in the direct clinical psychological care of adolescents with T1D at Nemours Children's Hospital - Delaware OR
  3. Involved in the scheduling and/or insurance coverage verification in the clinical psychological care of adolescents with T1D at Nemours Children's Hospital - Delaware OR
  4. Holds a leadership role in Endocrinology and/or Behavioral Health at Nemours Children's Hospital - Delaware

Exclusion Criteria:

1. Not involved in the direct clinical care or administrative parts of care of families with an adolescent with T1D at Nemours Children's Hospital - Delaware

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Implementation Toolkit
In this arm, all participants will receive BIT. If indicated, BIT-Enhanced will be deployed. All participants will receive BIT-Sustainment.
The Base Implementation Toolkit (BIT) includes strategies across pre-implementation, active implementation, and sustainment phases. Pre-implementation BIT strategies include provider and staff education meetings (e.g., meetings introducing processes for referring and delivering Diabetes Coaching), identification of and training the psychology providers and one medical provider as Champions for implementation and deliverer of Diabetes Coaching (psychology providers only), materials to increase demand for Diabetes Coaching among families (e.g., family-facing educational materials), and development of a workflow blueprint and of tools to monitor implementation. Active implementation BIT strategies include reporting summary level data on uptake of referrals to and family engagement in Diabetes Coaching to clinical type 1 diabetes providers, as well as facilitation (i.e., consultation) to support problem-solving workflow and other implementation challenges.
Other Names:
  • BIT-Enhanced
  • BIT-Sustainment
During active implementation, two strategies (audit and feedback, adapting delivery format and timing of Diabetes Coaching) may be added to BIT (BIT-Enhanced) to improve adoption among medical providers with lower referral rates (adoption rate <80%) and/or to increase reach if few families schedule and attend Diabetes Coaching (<6 families scheduled per group and/or <4 families attend group). BIT-Enhanced requires additional time and resources (e.g., Champions and providers review individual data, collaborate on ways to increase referrals). Thus, examining if these additional strategies meaningfully improve outcomes offers critical data for maintaining only the strategies that are necessary and sufficient for adoption, reach, and fidelity outcomes.
Key to maintaining implementation of any evidence-based practice, including Diabetes Coaching, is considering sustainability early on. The primary sustainability strategy (BIT-Sustainment) involves training multiple Champions early and planful progression of their role in the implementation efforts, from first participating in PI-led (implementation and content expert) consultation huddles and shadowing data tracking to then independently leading these huddles, reporting adoption data, and, for those requiring BIT-Enhanced, employing audit and feedback and reach data as needed. The BIT-Sustainment will be deployed for all providers (BIT and BITE) during the sustainment phase of implementation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of Implementation Strategies
Time Frame: Post-completion of Sustainment implementation strategies; 10 months
Total score on the Feasibility of Intervention Measure (FIM) for each implementation strategy. The FIM is a validated, brief, 4-item, survey on the feasibility of implementation strategies. Each item is rated on a 5-point Likert scale, from completely disagree (1) to completely agree (5), with higher scores indicating greater feasibility.
Post-completion of Sustainment implementation strategies; 10 months
Acceptability of Implementation Strategies
Time Frame: Post-completion of Sustainment implementation strategies (10 months)
Total score on the Acceptability of Intervention Measure (FIM) for each implementation strategy. The AIM is a validated, brief, 4-item, survey on the feasibility of implementation strategies. Each item is rated on a 5-point Likert scale, from completely disagree (1) to completely agree (5), with higher scores indicating greater acceptability.
Post-completion of Sustainment implementation strategies (10 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adoption of Referral Practices
Time Frame: Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Percentage of providers who reach adoption (total number of medical providers vs. number of medical providers referring >80% of eligible families per week) measured via electronic health record data.
Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Reach of Diabetes Coaching
Time Frame: Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Percent of eligible families completing at least 3 of 4 Diabetes Coaching sessions versus total number of eligible families (based on electronic health record data).
Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Fidelity of Delivering Diabetes Coaching
Time Frame: Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Percent of completed items on self-report checklists for delivering Diabetes Coaching sessions, as reported by psychology provider.
Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 26, 2026

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

April 30, 2027

Study Registration Dates

First Submitted

August 5, 2026

First Submitted That Met QC Criteria

August 10, 2026

First Posted (Actual)

August 17, 2026

Study Record Updates

Last Update Posted (Actual)

August 27, 2026

Last Update Submitted That Met QC Criteria

August 26, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified questionnaire responses will be shared. De-identified qualitative data from semi-structured interviews may be shared under a data use agreement. Recordings of qualitative interviews will not be shared publicly due to the potential of voice identification of participants. Original data will be maintained on a secure drive at Nemours Children's Hospital, Delaware. Metadata that will be made accessible to facilitate interpretation of scientific data include study protocols, consent forms, interview scripts, codebooks, questionnaires, data dictionaries, analysis codes, and other supporting documentation. The data dictionaries will define and describe all variables in the dataset.

IPD Sharing Time Frame

Beginning 3 months after the publication of results with no end date.

IPD Sharing Access Criteria

Investigators who have interest in the data for research purposes may access the IPD and supporting information. De-identified questionnaire responses will be shared. De-identified qualitative data from semi-structured interviews may be shared under a data use agreement. Recordings of qualitative interviews will not be shared publicly due to the potential of voice identification of participants. Original data will be maintained on a secure drive at Nemours Children's Hospital, Delaware. Metadata that will be made accessible to facilitate interpretation of scientific data include study protocols, consent forms, interview scripts, codebooks, questionnaires, data dictionaries, analysis codes, and other supporting documentation. The data dictionaries will define and describe all variables in the dataset. De-identified data will be available through openICPSR.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe